Abstract
In an attempt to develop a new class of selective antitumor agents, a novel series of benzothiazole derivatives was prepared via the condensation of 5-fluoro-6-(4-methylpiperazin-1-yl)benzo[d]thiazol-2- Amine with aromatic aldehydes. The preliminary bioassay reveals that (4-fluorobenzylidene)-[5-fluoro-6-(4-methylpiperazin-1-yl)-benzothiazol-2-yl]- Amine show specific anticancer cytotoxicity.
Original language | English |
---|---|
Pages (from-to) | 1282-1292 |
Number of pages | 11 |
Journal | Heterocycles |
Volume | 92 |
Issue number | 7 |
DOIs | |
Publication status | Published - 25 May 2016 |
IMC Research Focuses
- Medical biotechnology
ÖFOS 2012 - Austrian Fields of Study
- 304005 Medical biotechnology